CancerConsultants provides summaries of new treatment strategies as they are discovered and reported by cancer physicians around the world. Our medical staff attends medical meetings worldwide and reviews medical literature daily to ensure appropriate news is provided to cancer patients and their families in a timely manner.
News of the results of recent clinical trials evaluating cancer therapies and supportive care strategies serve to educate patients regarding new treatment strategies for cancer and facilitate discussions with their doctor. Development of new cancer treatments usually begins in patients with recurrent or metastatic cancers. Once the new treatment appears effective, it is applied to earlier stages of the disease or to patients at higher risk of treatment failure.
SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers (March 23, 2017)
People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy... Continue Reading
The ENDEAVOR trial results were updated at the 16th International Myeloma Workshop in New Delhi. The trial demonstrated that Kyprolis (Carfilzomib) not only significantly extended progression-free survival... Continue Reading
Have a Question about Cancer-Related Brain Fog? Ask the Expert! Live Web Chat Tuesday, March 28th, 4:00-5:00 PM, EST Tune in here. Join us for a live Ask the Expert session with neurocognitive expert Heather... Continue Reading
There are several recent advances of note in the management of all stages of Multiple Myeloma. Smoldering myeloma is considered to be a pre-cancerous condition, in which patients do not yet display any... Continue Reading
Results were recently presented at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer in National Harbor, USA, demonstrating that Lynparza (olaparib) reduced the risk of platinum-sensitive,... Continue Reading
The US Food and Drug Administration (FDA) has approved the investigational drug Kisqali® (ribociclib, LEE011) for first line treatment of hormone receptor + HER 2- metastatic breast cancer because when... Continue Reading
Patients with a type of advanced malignant cancer of the arms or legs have typically faced amputation of the afflicted limb as the only treatment option. However, a technique that limits the application... Continue Reading
For many years ovarian cancer has been referred to as “the silent killer” due to its vague, ignored, or misdiagnosed symptoms. Because of this and the lack of early-detection tools, ovarian cancer... Continue Reading